Insulin Injections Could Soon To Be Obsolete
Z79.4 - Long term (current) use of insulin
During my tenure in Home Health in Texas, a poignant memory lingers of an elderly diabetic couple grappling with the challenges of maintaining independence despite their legal blindness. The intricacies of drawing up their insulin became a formidable hurdle, casting a shadow on their aspirations for self-sufficiency. Home health, while not intended as a long-term solution, found itself as the sole recourse for setting up the necessary syringes, underscoring the poignant reality of their situation. As you can imagine this became an issue.
Embarking on a transformative journey for the 75 million daily insulin injectors worldwide, groundbreaking research in Nature Nanotechnology unveils a paradigm-shifting approach to insulin delivery. Imagine a capsule, minuscule nano-carriers, each narrower than 1/10,000th of a human hair, cradling insulin—an innovation poised to redefine diabetes care. Yet, a formidable hurdle emerges as stomach breakdown threatens to derail this medical breakthrough. Fear not, for researchers have ingeniously crafted a protective shield, guiding insulin through the digestive labyrinth to its crucial destination—the liver. This coating, attuned to soaring blood sugar levels, orchestrates a precisely timed insulin release, echoing the body's natural rhythms. Unlike traditional injections unleashing insulin all at once, this method curtails the peril of hypoglycemia, tailoring release to individual needs. Triumphant trials on nematodes, mice, rats, and baboons set the stage for human clinical exploration in 2025, holding the promise of widespread adoption within the next 2–3 years. Dive deeper into this medical marvel in the referenced article in Nature Nanotechnology.
REFERENCE:
Z79.4 - Long term (current) use of insulin
During my tenure in Home Health in Texas, a poignant memory lingers of an elderly diabetic couple grappling with the challenges of maintaining independence despite their legal blindness. The intricacies of drawing up their insulin became a formidable hurdle, casting a shadow on their aspirations for self-sufficiency. Home health, while not intended as a long-term solution, found itself as the sole recourse for setting up the necessary syringes, underscoring the poignant reality of their situation. As you can imagine this became an issue.
Embarking on a transformative journey for the 75 million daily insulin injectors worldwide, groundbreaking research in Nature Nanotechnology unveils a paradigm-shifting approach to insulin delivery. Imagine a capsule, minuscule nano-carriers, each narrower than 1/10,000th of a human hair, cradling insulin—an innovation poised to redefine diabetes care. Yet, a formidable hurdle emerges as stomach breakdown threatens to derail this medical breakthrough. Fear not, for researchers have ingeniously crafted a protective shield, guiding insulin through the digestive labyrinth to its crucial destination—the liver. This coating, attuned to soaring blood sugar levels, orchestrates a precisely timed insulin release, echoing the body's natural rhythms. Unlike traditional injections unleashing insulin all at once, this method curtails the peril of hypoglycemia, tailoring release to individual needs. Triumphant trials on nematodes, mice, rats, and baboons set the stage for human clinical exploration in 2025, holding the promise of widespread adoption within the next 2–3 years. Dive deeper into this medical marvel in the referenced article in Nature Nanotechnology.
REFERENCE:
- Hunt NJ, Lockwood GP, Heffernan SJ, Daymond J, Ngu M, Narayanan RK, . . . Cogger VC (2024) Oral nanotherapeutic formulation of insulin with reduced episodes of hypoglycaemia. Nature Nanotechnology. PMID: 38168926. URL: https://www.ncbi.nlm.nih.gov/pubmed/38168926 & https://www.nature.com/articles/s41565-023-01565-2.pdf